论文部分内容阅读
Objective: To assess the safety and efficacy of concurrent selective lymph node (SLN) late course accelerated hyperfractionated (LCAF) intensity-modulated radiotherapy (IMRT),as well as S-1 and cisplatin (CDDP) for locally advanced esophageal squamous cell carcinoma (ESCC).